Effect of Hyperosmolality on Vasopressin Secretion in Intradialytic Hypotension: A Mechanistic Study

American Journal of Kidney Diseases

Volumn 52, Issue 2, 2008, Pages 294-304

  Shimizu, Kurakazu ^a   Kurosawa, Takeshi ^a   Sanjo, Teizo ^a  

^a Sumiyoshi Clinic Hospital   (Japan)

Author keywords

Hemodialysis; hypotension; osmolality; plasma volume; vasopressin

Indexed keywords

ARGIPRESSIN; GLUCOSE; SODIUM CHLORIDE; VASOCONSTRICTOR AGENT;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; BLOOD VOLUME; CLINICAL ARTICLE; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; HYPEROSMOLALITY; HYPOTENSION; INTRAVENOUS ADMINISTRATION; LONG TERM CARE; MALE; MEAN ARTERIAL PRESSURE; PATHOPHYSIOLOGY; PLASMA OSMOLALITY; PLASMA VOLUME; VASOPRESSIN BLOOD LEVEL; VASOPRESSIN RELEASE;

AGED; AGED, 80 AND OVER; ARGININE VASOPRESSIN; BLOOD PRESSURE; BLOOD VOLUME; DIALYSIS SOLUTIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTONIC SOLUTIONS; HYPOTENSION; MALE; MIDDLE AGED; OSMOTIC PRESSURE; PROGNOSIS; RENAL DIALYSIS; RISK FACTORS; TIME FACTORS;

EID: 47149088868     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2008.03.024     Document Type: Article

References (36)

1. Bregman H., Daugirdas J.T., and Ing T.S. Complications during hemodialysis. In: Daugirdas J.T., and Ing T.S. (Eds). Handbook of Dialysis. (ed 2) (1994), Little Brown, Boston, MA 13-29
2. Mujais S.K., Ing T., and Kjellstrand C. Acute complications of hemodialysis and their prevention and treatment. In: Jacobs C., Kjellstrand C.M., Koch K.M., and Winchester J.F. (Eds). Replacement of Renal Function by Dialysis. (ed 4) (1996), Dordrecht, The Netherlands, Kluwer 688-725
3. Sulowicz W., and Radziszewski A. Pathogenesis and treatment of dialysis hypotension. Kidney Int Suppl 104 (2006) S36-S39
4. Daugirdas J.T. Preventing and managing hypotension. Semin Dial 7 (1994) 276-283
5. Gong R., Lindberg J., Abrams J., Whitaker W.R., Wade C.E., and Gouge S. Comparison of hypertonic saline solutions and dextran in dialysis-induced hypotension. J Am Soc Nephrol 3 (1993) 1808-1812
6. Shimizu K., Nakao A., Nonaka T., and Oka H. Identification of vasopressin and determination of its corticomedullary levels in rat kidney tissue. Kidney Int 26 (1984) 785-790
7. Shimizu K., Nakano S., Nakano Y., Ando M., Seki K., and Kameda N. Ectopic atrial natriuretic peptide production in small cell lung cancer with the syndrome of inappropriate antidiuretic hormone secretion. Cancer 68 (1991) 2284-2288
8. Rose B.D. The total body water and the plasma sodium concentration, in Clinical Physiology of Acid-Base and Electrolyte Disorders. (ed 4) (1994), McGraw-Hill, New York, NY 219-234
9. Sanderson N.A., and Katz M.A. The fate of hypertonic saline administered during hemodialysis. ANNA J 21 (1994) 162-170
10. Kinet J.P., Soyeur D., Balland N., Saint-Remy M., Collignon P., and Godon J.-P. Hemodynamic study of hypotension during hemodialysis. Kidney Int 21 (1982) 868-876
11. Robertson G.L., Shelton R.L., and Athar S. The osmoregulation of vasopressin. Kidney Int 10 (1976) 25-37
12. Nette R.W., Van den Dorpel M.A., Krepel H.P., et al. Hypotension during hemodialysis results from an impairment of arteriolar tone and left ventricular function. Clin Nephrol 63 (2005) 276-283
13. Emili S., Black N.A., Paul R.V., Rexing C.J., and Ullian M.E. A protocol-based treatment for intradialytic hypotension in hospitalized hemodialysis patients. Am J Kidney Dis 33 (1999) 1107-1114
14. Schmidt R., Roeher O., Hickstein H., and Korth S. Prevention of hemodialysis-induced hypotension by biofeedback control of ultrafiltration and infusion. Nephrol Dial Transplant 16 (2001) 595-603
15. Van der Sande F.M., Luik A.J., Kooman J.P., Verstappen V., and Leunissen K.M.L. Effect of intravenous fluids on blood pressure course during hemodialysis in hypotensive-prone patients. J Am Soc Nephrol 11 (2000) 550-555
16. Henrich W.L., Woodard T.D., and McPhaul J.J. The chronic efficacy and safety of high sodium dialysate: Double-blind, crossover study. Am J Kidney Dis 2 (1982) 349-353
17. Van Kuijk W.H.M., Wirtz J.J.J.M., Grave W., et al. Vascular reactivity during combined ultrafiltration-hemodialysis: Influence of dialysate sodium. Nephrol Dial Transplant 11 (1996) 323-328
18. Henrich W.L., Woodard T.D., Blanchley J.D., Gomez-Sanchez C., Pettinger W., and Cronin R.E. Role of osmolality in blood pressure stability after dialysis and ultrafiltration. Kidney Int 18 (1980) 480-488
19. Velasco I.T., Pontieri V., Rocha e Silva Jr. M., and Lopes O.U. Hyperosmotic NaCl and severe hemorrhagic shock. Am J Physiol 239 (1980) H664-H673
20. Horký K., Srámková J., Lachmanová J., Tomásek R., and Dvoráková J. Plasma concentration of antidiuretic hormone in patients with chronic renal insufficiency on maintenance dialysis. Horm Metab Res 11 (1979) 241-246
21. Fasanella d'Amore T., Wauters J.P., Waeber B., Nussberger J., and Brunner H.R. Response of plasma vasopressin to changes in extracellular volume and/or plasma osmolality in patients on maintenance hemodialysis. Clin Nephrol 23 (1985) 299-302
22. Jawadi M.H., Ho L.S., Dipette D., and Ross D.L. Regulation of plasma arginine vasopressin in patients with chronic renal failure maintained on hemodialysis. Am J Nephrol 6 (1986) 175-181
23. Ardaillou R., Banmansour M., and Pruszczynski W. Secretion and metabolism of vasopressin in chronic renal failure. In: Cowley Jr. A.W., Liard J.-F., and Ausiello D.A. (Eds). Vasopressin: Cellular and Integrative Functions (1988), Raven, New York, NY 241-247
24. Lindberg J.S., Copley J.B., Melton K., Wade C.E., Abrams J., and Goode D. Lysine vasopressin in the treatment of refractory hemodialysis-induced hypotension. Am J Nephrol 10 (1990) 269-275
25. Van der Zee S., Thompson A., Zimmerman R., et al. Vasopressin administration facilitates fluid removal during hemodialysis. Kidney Int 71 (2007) 318-324
26. Shimizu K., and Hoshino M. Application of vasopressin radioimmunoassay to clinical study: Role of vasopressin in hypo- and hypernatremia and some other disorders of water metabolism. Contrib Nephrol 9 (1978) 42-60
27. Shimizu K., Hamazaki T., Ubukata E., Shiratori Y., and Harada M. Trials for simplified hypertonic saline test. Folia Endocrinol 63 (1987) 164-171
28. Zerbe R.I., and Robertson G.L. Osmoregulation of thirst and vasopressin secretion in human subjects: Effect of various solutes. Am J Physiol 244 (1983) E607-E614
29. Wagner H.N., and Braunwald E. The pressor effect of the antidiuretic principle of the posterior pituitary in orthostatic hypotension. J Clin Invest 35 (1956) 1412-1418
30. Cowley Jr. A.W., and Liard J.F. Cardiovascular actions of vasopressin. In: Gash D.M., and Boer G.J. (Eds). Vasopressin, Principles and Properties (1987), Plenum, New York 389-433
31. Montani J.P., Liard J.F., Schoun J., and Möhring J. Hemodynamic effects of exogenous and endogenous vasopressin at low plasma concentrations in conscious dogs. Circ Res 47 (1980) 346-355
32. Möhring J., Glänzer K., Maciel Jr. J.A., et al. Greatly enhanced pressor response to antidiuretic hormone in patients with impaired cardiovascular reflexes due to idiopathic orthostatic hypotension. J Cardiovasc Pharmacol 2 (1980) 367-376
33. Friess U., Rascher W., Ritz E., and Gross P. Failure of arginine-vasopressin and other pressor hormones to increase in severe recurrent dialysis hypotension. Nephrol Dial Transplant 10 (1995) 1421-1427
34. Robertson G.L. Posterior pituitary. In: Felig P., Baxter J., and Frohman L.A. (Eds). Endrocrinology and Metabolism (1986), McGraw-Hill, New York, NY 338-386
35. Lundvall J., and Lindgren P. F-Cell shift and protein loss strongly affect validity of PV reductions indicated by Hb/Hct and plasma proteins. J Appl Physiol 84 (1998) 822-829
36. Dasselaar J.J., Lub-de Hooge M.N., Pruim J., et al. Relative blood volume changes underestimate total blood volume changes during hemodialysis. Clin J Am Soc Nephrol 2 (2007) 669-674